Ophthalmic genetics · 2025
A case of paternity-confirmed de novo R124H mutation resulting in granular corneal dystrophy type 2.
СтатьяКлинический случайПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Min Ji Sang, Kim Tae-Im, Shin Kyoung-Jin, Choi Jinseok, Stulting R Doyle, Kim Eung Kweon
Аннотация
PURPOSE: To report the first case of granular corneal dystrophy type 2 (GCD2) caused by a de novo p.(Arg124His) mutation that was confirmed by paternity testing in a 13-year-old male patient referred for the evaluation of corneal opacities in the left eye.Study design: Clinical case report.
METHODS: The p.(Arg124His) mutation was identified using direct Sanger sequencing of the entire TGFBI gene. The patient's parents and sister also underwent ophthalmological examination and direct Sanger sequencing of the entire TGFBI gene.
RESULTS: No abnormal findings on ophthalmic examination or genetic mutations were found in the parents. In addition, the patient's biological parents were confirmed using DNA paternity testing.
CONCLUSION: A negative family history of GCD2 and the absence of GCD2 in the parents of patients seeking refractive surgery are not sufficient to exclude a diagnosis of GCD2 because some cases of GCD2 arise from de novo mutations. Exclusion of GCD2 before refractive surgery requires genetic analysis for the p.(Arg124His) mutation.
METHODS: The p.(Arg124His) mutation was identified using direct Sanger sequencing of the entire TGFBI gene. The patient's parents and sister also underwent ophthalmological examination and direct Sanger sequencing of the entire TGFBI gene.
RESULTS: No abnormal findings on ophthalmic examination or genetic mutations were found in the parents. In addition, the patient's biological parents were confirmed using DNA paternity testing.
CONCLUSION: A negative family history of GCD2 and the absence of GCD2 in the parents of patients seeking refractive surgery are not sufficient to exclude a diagnosis of GCD2 because some cases of GCD2 arise from de novo mutations. Exclusion of GCD2 before refractive surgery requires genetic analysis for the p.(Arg124His) mutation.